-logo-1200x675.png?v=20220915161652&w=240&h=240&zc=2){kind=logo}
Madrigal Pharmaceuticals (NASDAQ:MDGL) Stock Price Expected to Rise, HC Wainwright Analyst Says
Madrigal Pharmaceuticals (NASDAQ:MDGL – Get Free Report) had its target price increased by analysts at HC Wainwright from $400.00 to $405.00 in a research note issued to investors on Thursday, MarketBeat.com reports. The firm presently has a “buy” rating on the biopharmaceutical company’s stock. HC Wainwright’s target price suggests a potential upside of 18.67% from […]
Madrigal Pharmaceuticals (NASDAQ:MDGL – Get Free Report) had its target price increased by analysts at HC Wainwright from $400.00 to $405.00 in a research note issued to investors on Thursday, MarketBeat.com reports. The firm presently has a “buy” rating on the biopharmaceutical company’s stock. HC Wainwright’s target price suggests a potential upside of 18.67% from […]
